Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma

Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma

The nonnegligible reason for the poor prognosis of hepatocellular carcinoma (HCC) is resistance to conventional chemotherapy. Immunogenic cell death (ICD) is a rare immunostimulatory form of cell death that can reengage the tumor-specific immune system. ICD can improve the clinical outcomes of chemo...

Full description

Bibliographic Details
Main Authors: Zhongren Xu, Jianqiang Xu, Shibo Sun, Wei Lin, Yongming Li, Qiuyue Lu, Fuwei Li, Zhibin Yang, Yunlong Lu, Wukun Liu
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Redox Biology
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231722001239

Internet

http://www.sciencedirect.com/science/article/pii/S2213231722001239

Similar Items